Illumina (Singapore)
Illumina’s Singapore-based regional operation supporting genomic sequencing and array-based solutions for research, translational genomics, consumer genomics, and molecular diagnostics.
Last updated August 28, 2026
Overview
Illumina (Singapore) is the Singapore-based operation of Illumina, Inc., a life-science technology company focused on genomic analysis. It represents Illumina’s products and activities in Singapore and within the wider Asia-Pacific region, using the company’s regional web presence to provide information about sequencing and array-based technologies. The operation is associated with Illumina’s portfolio of genomic research tools, including next-generation sequencing systems, sequencing consumables, array technologies, and related software and services. These technologies are used by research institutions, clinical and translational laboratories, pharmaceutical and biotechnology organizations, and other customers working in genomics. Applications described by Illumina include life-science research, translational and consumer genomics, and molecular diagnostics. As a country or regional subsidiary rather than an independently documented global brand, Illumina (Singapore) does not have a separately established public history, founder record, financial profile, or independently listed stock ticker in the available reference material. Its identity and commercial scope are instead derived from its relationship with Illumina, Inc. and the company’s Asia-Pacific activities. The Singapore operation serves as a local point of presence for a global genomics technology portfolio and may support customer engagement, product information, commercial activity, and regional access to Illumina platforms. The broader Illumina brand is known for sequencing and array technologies intended to advance the study of genetic variation and biological systems. In Singapore, the relevant offering is therefore best understood as a business-to-business and institutional life-science technology portfolio rather than a consumer-facing standalone product brand. Specific local facilities, leadership appointments, incorporation dates, customer contracts, revenue figures, and market-share data were not established by the supplied sources.
History
Illumina (Singapore) is presented in the available material as Illumina’s Singapore-based company or regional operation. The supplied reference identifies the entity as a company in Singapore and associates it with Illumina’s Asia-Pacific web presence. No separate founding date, founder, incorporation history, local listing, or independently reported corporate milestones were provided. Its business context comes from Illumina’s broader genomics technology activities. Illumina develops sequencing and array-based solutions that support genetic and genomic analysis. The company describes applications spanning life-science research, translational and consumer genomics, and molecular diagnostics. The Singapore operation therefore functions within a wider regional and global commercial structure rather than as an independent technology developer with a distinct product architecture. The Singapore presence is relevant to customers and institutions seeking access to Illumina genomic technologies in Singapore and neighboring Asia-Pacific markets. Its product scope is associated with sequencing instruments, sequencing reagents and other consumables, array-based analysis technologies, and related software or services. These offerings can support research workflows and applied genomics, although the available material does not specify which products are stocked, serviced, or contracted locally. No reliable standalone Wikipedia article or detailed public historical record was supplied for Illumina (Singapore). Consequently, the entity should be documented conservatively as a regional subsidiary or operation of Illumina, Inc. rather than as a separately founded brand. Further verification would be needed for local executives, legal entity details, office history, local partnerships, regulatory approvals, financial results, and product-launch dates.
Products and positioning
A regional life-science-tools operation providing access to Illumina’s genomic sequencing and array technologies for research and applied genomics customers in Singapore and the Asia-Pacific region.
Illumina sequencing platformsNext-generation sequencing
Sequencing instruments associated with Illumina’s genomic analysis portfolio. They are designed to generate sequencing data for applications in life-science research and other genomics workflows. The supplied material confirms the regional relevance of Illumina sequencing technologies but does not identify a specific platform model or Singapore-specific launch.
Sequencing reagents and consumablesGenomics consumables
Reagents and consumable components used with Illumina sequencing workflows. These products support the preparation and processing of genomic samples and are part of the recurring laboratory supply associated with sequencing systems. No locally specific catalog, pricing, or distribution information was provided.
Array-based genomic analysis solutionsGenomic arrays
Array technologies for analyzing genetic variation and other genomic characteristics. Illumina identifies array-based solutions alongside sequencing as a core technology area. The available sources do not establish which array products or configurations are specifically offered through the Singapore operation.
Flagship businesses
- Illumina sequencing platforms
- Illumina array-based genomic analysis solutions
Sources
Cite this profile: Cite the canonical profile. /brand-wiki/illumina-singapore · Editorial policy · How profiles are compiled